Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer

Oral Oncology

Volumn 46, Issue 2, 2010, Pages 100-104

  D'Souza, Gypsyamber ^a   Zhang, Hao H ^b   D'Souza, Warren D ^b   Meyer, Robert R ^c   Gillison, Maura L ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c University of Wisconsin Madison   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Antibodies; Cancer; HNSCC; HPV; Human papillomavirus; In situ; Machine learning; Oral HPV; Oropharyngeal; Prediction; Profiling; Screening; Tobacco; Tumor

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; DNA; PROTEIN E6; PROTEIN E7;

ADULT; AGED; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IN SITU HYBRIDIZATION; LABORATORY TEST; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIAL STATUS; TUMOR VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; DECISION TREES; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 74649085290     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.11.004     Document Type: Article

References (20)

1. Gillison M.L., D'Souza G., Westra W., Sugar E., Xiao W., Begum S., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100 6 (2008) 407-420
2. WHO. IARC monographs on the evaluation of carcinogenic risks to humans (2007), International Agency for Research on Cancer, Lyon, France
3. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 2 (2005) 467-475
4. Benard V.B., Johnson C.J., Thompson T.D., Roland K.B., Lai S.M., Cokkinides V., et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 113 Suppl. 10 (2008) 2910-2918
5. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 9 (2000) 709-720
6. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 4 (2008) 261-269
7. Chen L.M., Li G., Reitzel L.R., Pytynia K.B., Zafereo M.E., Wei Q., et al. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila PA) 2 9 (2009) 782-791
8. Huang C.C., Qiu J.T., Kashima M.L., Kurman R.J., and Wu T.C. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 11 10 (1998) 971-977
9. Adelstein D.J., Ridge J.A., Gillison M.L., Chaturvedi A.K., D'Souza G., Gravitt P.E., et al. Squamous cell head and neck cancer and the human papillomavirus: summary of a state of the science meeting, November 9-10, 2008, Washington, DC. Head Neck 31 (2009) 1391-1422
10. Viscidi R.P., Ahdieh-Grant L., Clayman B., Fox K., Massad L.S., Cu-Uvin S., et al. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 187 2 (2003) 194-205
11. Gange S.J., Barron Y., Greenblatt R.M., Anastos K., Minkoff H., Young M., et al. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health 56 2 (2002) 153-159
12. Gravitt P.E., Peyton C., Wheeler C., Apple R., Higuchi R., and Shah K.V. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 112 1-2 (2003) 23-33
13. Kotsiantis S.B. Supervised machine learning: a review of classification techniques. Informatica 31 (2007) 249-268
14. Witten I., and Frand E. Data mining: practical machine learning tools and techniques. 2nd ed. (2005), Morgan Kaufmann, San Francisco
15. Platt J. Fast training of support vector machines using sequential minimal optimization. In: Burges C.J.C. (Ed). Advances in kernel methods: support vector learning (1999), MIT Press Cambridge, MA, USA 185-208
16. Shevade S.K., Keerthi S.S., Bhattacharyya C., and Murthy K.K. Improvements to the SMO algorithm for SVM regression. IEEE Trans Neural Netw 11 5 (2000) 1188-1193
17. Kumar B., Cordell K.G., Lee J.S., Worden F.P., Prince M.E., Tran H.H., et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26 19 (2008) 3128-3137
18. Kumar B., Cordell K.G., Lee J.S., Prince M.E., Tran H.H., Wolf G.T., et al. Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys 69 Suppl. 2 (2007) S109-S111
19. Gravitt P., and Viscidi R. Measurement of exposure to human papillomavirus. In: Rohan T., and Shah K. (Eds). Cervical cancer: from etiology to prevention (2004), Kluwer Academic Publishers, London 119-141 [chapter 5]
20. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356 19 (2007) 1944-1956